Stock Events

Stock Events

Ventripoint Diagnostics 

$0.09
20
+$0+0.76% Today

Statistics

Day High
0.09
Day Low
0.09
52W High
0.12
52W Low
0.06
Volume
102,500
Avg. Volume
104,327
Mkt Cap
14.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
-0.01
-0
0
Expected EPS
N/A
Actual EPS
-0.0042

Financials

-5,144.5%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
136,036.42Revenue
-7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VPTDF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap325.88B
General Electric, through its healthcare division, offers advanced imaging and diagnostic technologies that compete with Ventripoint's heart analysis systems.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Philips, a leading health technology company, provides a range of diagnostic imaging technologies, including ultrasound, which competes with Ventripoint's cardiac analysis solutions.
Siemens
SIEGY
Mkt Cap224.45B
Siemens Healthineers offers a comprehensive portfolio of diagnostic imaging and laboratory diagnostics equipment, directly competing with Ventripoint's diagnostic solutions.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides a variety of analytical instruments, including imaging technologies, that serve the same market as Ventripoint's diagnostic products.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a wide range of diagnostic solutions, including cardiac imaging technologies that compete with Ventripoint's offerings.
Medtronic
MDT
Mkt Cap116.33B
Medtronic provides medical devices and technology, including cardiac diagnostic and monitoring tools, that compete with Ventripoint's heart analysis systems.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific specializes in medical devices that include cardiovascular diagnostic and therapeutic products, competing with Ventripoint's technologies.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, known for its robotic-assisted surgical systems, also delves into diagnostic imaging, indirectly competing with Ventripoint's diagnostic imaging solutions.
Hologic
HOLX
Mkt Cap16.45B
Hologic specializes in diagnostic products, including imaging systems for women's health, which can be seen as indirect competitors to Ventripoint's cardiac diagnostic tools.
Baxter International
BAX
Mkt Cap9.49B
Baxter International offers a range of medical devices and laboratory equipment that, while not directly competing in cardiac diagnostics, serves the broader diagnostic market alongside Ventripoint.

About

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Show more...
CEO
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.
Country
CA
ISIN
CA92281P2008

Listings

OTC Link
US
VPTDF
F
DE
5V7.F
V
CA
VPT.V

0 Comments

Share your thoughts

FAQ

What is Ventripoint Diagnostics stock price today?▼
The current price of VPTDF is $0.09 USD — it has increased by +0.76% in the past 24 hours. Watch Ventripoint Diagnostics stock price performance more closely on the chart.
What is Ventripoint Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ventripoint Diagnostics stocks are traded under the ticker VPTDF.
Is Ventripoint Diagnostics stock price growing?▼
VPTDF stock has fallen by -0.19% compared to the previous week, the month change is a +8.09% rise, over the last year Ventripoint Diagnostics has showed a -30.22% decrease.
What is Ventripoint Diagnostics market cap?▼
Today Ventripoint Diagnostics has the market capitalization of 14.31M
What were Ventripoint Diagnostics earnings last quarter?▼
VPTDF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ventripoint Diagnostics revenue for the last year?▼
Ventripoint Diagnostics revenue for the last year amounts to 136,036.42 USD.
What is Ventripoint Diagnostics net income for the last year?▼
VPTDF net income for the last year is -7M USD.
In which sector is Ventripoint Diagnostics located?▼
Ventripoint Diagnostics operates in the Health Care sector.
When did Ventripoint Diagnostics complete a stock split?▼
The last stock split for Ventripoint Diagnostics was on December 07, 2015 with a ratio of 1:10.
Where is Ventripoint Diagnostics headquartered?▼
Ventripoint Diagnostics is headquartered in Toronto, CA.